Y Intercept Hong Kong Ltd Takes Position in Maximus, Inc. (NYSE:MMS)

Y Intercept Hong Kong Ltd bought a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund bought 25,616 shares of the health services provider's stock, valued at approximately $1,747,000.

A number of other institutional investors have also recently modified their holdings of the business. Captrust Financial Advisors acquired a new stake in Maximus in the 4th quarter worth about $276,000. GAMMA Investing LLC boosted its stake in shares of Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after acquiring an additional 294 shares during the last quarter. Blue Trust Inc. increased its position in shares of Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares in the last quarter. Janney Montgomery Scott LLC increased its position in shares of Maximus by 70.5% during the first quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock worth $692,000 after purchasing an additional 4,196 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. raised its stake in Maximus by 24.0% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 6,461 shares of the health services provider's stock valued at $441,000 after purchasing an additional 1,249 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director directly owned 14,205 shares in the company, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.60% of the company's stock.

Maximus Price Performance

Shares of Maximus stock traded down $0.21 on Friday, hitting $73.42. 556,595 shares of the company were exchanged, compared to its average volume of 388,516. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.87. The stock has a market capitalization of $4.14 billion, a price-to-earnings ratio of 14.60 and a beta of 0.61. The company has a 50-day moving average price of $71.45 and a 200 day moving average price of $70.67.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The company had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.29 billion. During the same period in the prior year, the business earned $1.57 EPS. The firm's quarterly revenue was up 1.0% on a year-over-year basis. As a group, sell-side analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.63%. Maximus's dividend payout ratio is currently 23.86%.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.